Uncategorised - European Medical Journal

Interview: Yaakov Stern

When I was doing my BA in psychology, I found myself more interested in the research side of the subject; a lot of people who were…

AAN 2024 Abstract Highlights

AGE-related cognitive decline leads to greater entropic descriptiveness in connected speech tasks, according to new research presented at…

Updated Study Data for Ozanimod in Relapsing Multiple Sclerosis

Presenting data from ENLIGHTEN and DAYBREAK, covering cognitive processing, brain volume, disability progression, rebound, and…

Ozanimod Long-Term Safety and Efficacy

S1P receptor 1 and 5 modulator for relapsing forms of MS in adults, including clinically isolated syndrome, relapsing-remitting disease…

New Frontiers in Alzheimer’s Disease

THIS YEAR’s American Academy of Neurology (AAN) Annual Meeting, held in Denver, Colorado, USA, from April 13–18, featured an insightful…

Emerging Neuroinfectious Diseases

Delve into research regarding newly recognized pathogens, and the challenges they present to global health. Discussions explored a range…

Hypnosis: A Magical Tool in Clinical Scenarios – Part 2

In this second instalment, Sarah Partridge discusses success stories of hypnosis in a medical setting, and the potential benefits it provides to patient care.

Interview: Rizwan Rajak

Ever since medical school, I was always interested in musculoskeletal medicine and found this one of the most compelling subjects…

JHEP Reports: New Opinion Paper Published on the Diagnosis and Treatment of PFIC

This video summarises the key recommendations of a new opinion paper by McKiernan JP et al on the diagnosis and treatment …

Many Childhood Cancer Survivors Do Not Undergo Recommended Tests For Late Effects

A new retrospective cohort study has revealed concerning findings about the adherence to surveillance guidelines among adult survivors of childhood cancer in Ontario, Canada.